Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10
Cheng Cui, Helin Feng, Xinli Shi, et al.
International Immunopharmacology (2015) Vol. 27, Iss. 1, pp. 110-121
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang, Jin Xu, Bo Zhang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 968
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 453
Natural compounds and combination therapy in colorectal cancer treatment
Alexandra Rejhova, Alena Opattová, Andrea Čumová, et al.
European Journal of Medicinal Chemistry (2017) Vol. 144, pp. 582-594
Closed Access | Times Cited: 325
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
Yin Kwan Wong, Chengchao Xu, Karunakaran Kalesh, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1492-1517
Closed Access | Times Cited: 215
Natural products and their derivatives: Promising modulators of tumor immunotherapy
Lijuan Deng, Ming Qi, Nan Li, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 2, pp. 493-508
Open Access | Times Cited: 157
Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Jigang Wang, Chengchao Xu, Yin Kwan Wong, et al.
Engineering (2018) Vol. 5, Iss. 1, pp. 32-39
Open Access | Times Cited: 157
Old wine in new bottles: Drug repurposing in oncology
Michał Antoszczak, Anna Markowska, Janina Markowska, et al.
European Journal of Pharmacology (2019) Vol. 866, pp. 172784-172784
Closed Access | Times Cited: 78
Antitumor Research on Artemisinin and Its Bioactive Derivatives
Yunqin Zhang, Guowei Xu, Shuqun Zhang, et al.
Natural Products and Bioprospecting (2018) Vol. 8, Iss. 4, pp. 303-319
Open Access | Times Cited: 83
Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
Amna Parveen, Lalita Subedi, H. Kim, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 3, pp. 350-350
Open Access | Times Cited: 68
Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
Cangcang Xu, Huihui Zhang, Lingli Mu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 63
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 31
Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells
Yilin Pang, Guiqi Qin, Liping Wu, et al.
Experimental Cell Research (2016) Vol. 347, Iss. 2, pp. 251-260
Closed Access | Times Cited: 47
In–Situ‐Sprayed Dual‐Functional Immunotherapeutic Gel for Colorectal Cancer Postsurgical Treatment
Xinghui Si, Guofeng Ji, Sheng Ma, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 20
Closed Access | Times Cited: 33
Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinomaviacreating a cancer-supportive niche
Xiaowen Xu, Wenjun Chang, Jie Yuan, et al.
Oncotarget (2015) Vol. 7, Iss. 1, pp. 798-813
Open Access | Times Cited: 46
Artesunate promotes Th1 differentiation from CD4+ T cells to enhance cell apoptosis in ovarian cancer via miR-142
Xiao Chen, Xueling Zhang, Guohua Zhang, et al.
Brazilian Journal of Medical and Biological Research (2019) Vol. 52, Iss. 5
Open Access | Times Cited: 39
Prevention of carcinogenesis and metastasis by Artemisinin-type drugs
Mohammed Abba, Nitin Patil, Jörg H. Leupold, et al.
Cancer Letters (2018) Vol. 429, pp. 11-18
Closed Access | Times Cited: 38
Artesunate prevents type 1 diabetes in NOD mice mainly by inducing protective IL‐4—producing T cells and regulatory T cells
Zhixia Li, Xiajie Shi, Junbin Liu, et al.
The FASEB Journal (2019) Vol. 33, Iss. 7, pp. 8241-8248
Open Access | Times Cited: 36
Progress on the study of the anticancer effects of artesunate (Review)
Xiulan Yang, Yudong Zheng, Lian Liu, et al.
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 31
The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future
Hung‐Yu Lin, Hui‐Wen Ho, Yen‐Hsiang Chang, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4576-4576
Open Access | Times Cited: 27
Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy
Qi Shang, Wandong Liu, Faith Leslie, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 4, pp. 1525-1541
Open Access | Times Cited: 11
Artesunate: A Review of Its Potential Therapeutic Effects and Mechanisms in Digestive Diseases
Mengting Shi, Guanhua Ma, Xiulan Yang
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 299-299
Open Access
Artesunate enhances γδ T-cell-mediated antitumor activity through augmenting γδ T-cell function and reversing immune escape of HepG2 cells
Qian Peng, Zhang Yong-wen, Zhong-Hai Zhou, et al.
Immunopharmacology and Immunotoxicology (2018) Vol. 40, Iss. 2, pp. 107-116
Closed Access | Times Cited: 27
Redirecting the focus of cancer immunotherapy to premalignant conditions
Matthew R. Young
Cancer Letters (2017) Vol. 391, pp. 83-88
Open Access | Times Cited: 26
In situ probing of cell–cell communications with surface-enhanced Raman scattering (SERS) nanoprobes and microfluidic networks for screening of immunotherapeutic drugs
Lei Wu, Zhuyuan Wang, Yizhi Zhang, et al.
Nano Research (2016) Vol. 10, Iss. 2, pp. 584-594
Closed Access | Times Cited: 25
Artemisinin sensitizes tumor cells to NK cell-mediated cytolysis
Zhen Lu, Jiacheng Bi, Xiaochun Wan
Biochemical and Biophysical Research Communications (2020) Vol. 524, Iss. 2, pp. 418-423
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top